Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Cash (2022 - 2023)

Historic Change in Cash for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $86.0 million.

  • Lexeo Therapeutics' Change in Cash rose 61157.96% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.1 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 29590.3% down from last year.
  • Per Lexeo Therapeutics' latest filing, its Change in Cash stood at $86.0 million for Q4 2023, which was up 61157.96% from -$10.1 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Change in Cash registered a high of $86.0 million during Q4 2023, and its lowest value of -$18.5 million during Q1 2023.